FR2113774A1 - Prepn of l-ornithine salts with org acids - using silver oxides - Google Patents

Prepn of l-ornithine salts with org acids - using silver oxides

Info

Publication number
FR2113774A1
FR2113774A1 FR7040754A FR7040754A FR2113774A1 FR 2113774 A1 FR2113774 A1 FR 2113774A1 FR 7040754 A FR7040754 A FR 7040754A FR 7040754 A FR7040754 A FR 7040754A FR 2113774 A1 FR2113774 A1 FR 2113774A1
Authority
FR
France
Prior art keywords
org
prepn
acids
silver oxides
ornithine salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7040754A
Other languages
English (en)
French (fr)
Other versions
FR2113774B1 (forum.php
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROQUES ETS
Original Assignee
ROQUES ETS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROQUES ETS filed Critical ROQUES ETS
Priority to FR7040754A priority Critical patent/FR2113774A1/fr
Publication of FR2113774A1 publication Critical patent/FR2113774A1/fr
Application granted granted Critical
Publication of FR2113774B1 publication Critical patent/FR2113774B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7040754A 1970-11-13 1970-11-13 Prepn of l-ornithine salts with org acids - using silver oxides Granted FR2113774A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7040754A FR2113774A1 (en) 1970-11-13 1970-11-13 Prepn of l-ornithine salts with org acids - using silver oxides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7040754A FR2113774A1 (en) 1970-11-13 1970-11-13 Prepn of l-ornithine salts with org acids - using silver oxides

Publications (2)

Publication Number Publication Date
FR2113774A1 true FR2113774A1 (en) 1972-06-30
FR2113774B1 FR2113774B1 (forum.php) 1974-03-22

Family

ID=9064117

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7040754A Granted FR2113774A1 (en) 1970-11-13 1970-11-13 Prepn of l-ornithine salts with org acids - using silver oxides

Country Status (1)

Country Link
FR (1) FR2113774A1 (forum.php)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2441607A1 (fr) * 1978-11-20 1980-06-13 Tanabe Seiyaku Co Sels cristallins de l-amino-acide basique et d'acide l-malique, utiles notamment pour le traitement de l'hyperammoniemie, et leur procede de preparation
FR2634374A1 (fr) * 1988-07-19 1990-01-26 Serobiologiques Lab Sa Agents photoprotecteurs, cytophotoprotecteurs cutanes ayant une activite photoprotectrice des cellules constitutives, fonctionnelles de la peau, en particulier des cellules de langerhans, a base de composes nucleiques : nucleoprotides, ribonucleotides et desoxyribonucleotides, ribonucleosides et desoxyribonucleosides, compositions cosmetiques ou dermo-pharmaceutiques contenant un tel agent ainsi que des nouveaux composes en soi
JPWO2006001378A1 (ja) * 2004-06-25 2008-04-17 協和醗酵工業株式会社 L−オルニチン・クエン酸塩結晶
US10039735B2 (en) 2014-11-24 2018-08-07 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10173964B2 (en) 2009-04-03 2019-01-08 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US10610506B2 (en) 2004-11-26 2020-04-07 Ucl Business Ltd Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
US11066352B2 (en) 2017-05-11 2021-07-20 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate
US11266620B2 (en) 2009-06-08 2022-03-08 Ucl Business Ltd Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2441607A1 (fr) * 1978-11-20 1980-06-13 Tanabe Seiyaku Co Sels cristallins de l-amino-acide basique et d'acide l-malique, utiles notamment pour le traitement de l'hyperammoniemie, et leur procede de preparation
US4420432A (en) * 1978-11-20 1983-12-13 Tanabe Seiyaku Co., Ltd. Crystalline salt of basic L-amino acid with L-malic acid and process for the preparation thereof
FR2634374A1 (fr) * 1988-07-19 1990-01-26 Serobiologiques Lab Sa Agents photoprotecteurs, cytophotoprotecteurs cutanes ayant une activite photoprotectrice des cellules constitutives, fonctionnelles de la peau, en particulier des cellules de langerhans, a base de composes nucleiques : nucleoprotides, ribonucleotides et desoxyribonucleotides, ribonucleosides et desoxyribonucleosides, compositions cosmetiques ou dermo-pharmaceutiques contenant un tel agent ainsi que des nouveaux composes en soi
JPWO2006001378A1 (ja) * 2004-06-25 2008-04-17 協和醗酵工業株式会社 L−オルニチン・クエン酸塩結晶
JP4796494B2 (ja) * 2004-06-25 2011-10-19 協和発酵バイオ株式会社 L−オルニチン・クエン酸塩結晶
US10610506B2 (en) 2004-11-26 2020-04-07 Ucl Business Ltd Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US10173964B2 (en) 2009-04-03 2019-01-08 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US10550069B2 (en) 2009-04-03 2020-02-04 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US11161802B2 (en) 2009-04-03 2021-11-02 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US11266620B2 (en) 2009-06-08 2022-03-08 Ucl Business Ltd Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
US10525029B2 (en) 2014-11-24 2020-01-07 Ucl Business Ltd Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10039735B2 (en) 2014-11-24 2018-08-07 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US11040021B2 (en) 2014-11-24 2021-06-22 Ucl Business Ltd Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
US11066352B2 (en) 2017-05-11 2021-07-20 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate

Also Published As

Publication number Publication date
FR2113774B1 (forum.php) 1974-03-22

Similar Documents

Publication Publication Date Title
BR7205613D0 (pt) Preparacao do acido glioxolico por reducao catodica de acido oxalico
FR2113774A1 (en) Prepn of l-ornithine salts with org acids - using silver oxides
JPS5598187A (en) Manufacture of 33methylldelta33cephemm44carboxylic acid compound
AU3233371A (en) Improved treatment of phosphoric acid to recover alkali metal fluositicates
MY7800085A (en) Purification of phosphoric acid
JPS5639093A (en) Manufacture of oosubstitutedd7 betaaaminoo33 cephemm33oll44carboxylic acid compound
CA929535A (en) Manufacture of levulinic acid
IL36006A0 (en) Purification of phosphoric acid
IT951067B (it) Procedimento per produrre acido pirofosforico
EG12694A (en) Purification of phosphoric acid
ES402670A1 (es) Un procedimiento para la preparacion de nuevos acidos ben- zamidoacetohidroxamicos.
IT982777B (it) Procedimento per la purificazione di acido fosforico commerciale mediante estrazione
CA956324A (en) Manufacture of pure alkali metal salts of aminopolycarboxylic acids
IT938967B (it) Procedimento per la purificazione di acido fosforico commerciale
IT1013007B (it) Procedimento per la fabbricazione di acido citrico mediante fermentazione sommersa
IT941705B (it) Procedimento per fabbricare acido citrico mediante fermentazione sommersa
IT958815B (it) Perfezionamenti ai procedimenti per la fabbricazione di acido fosforico
AU457963B2 (en) Purification of phosphoric acid
AU271059B2 (en) Production of alkali metal salts of isoacrobic acid
AU282226B2 (en) Method of producing the anhydrous salt of fumaric acid with bivalent iron
AU2435271A (en) Purification of phosphoric acid
JPS5762286A (en) Manufacture of 7beta-amino-cephem-4-carboxylic acid compound
CA877213A (en) Purification of phosphoric acid
CA865019A (en) Process for purification of phosphoric acid
CA654178A (en) Process for producing salts of thiopseudoureido-octanoic acid

Legal Events

Date Code Title Description
ST Notification of lapse